iShares Genomics Immunology and Healthcare ETF (IDNA) Holdings
IDNA holdings summary
as of Oct 25, 2026- Holdings
- 47 positions listed
- Top 10 weight
- 48.2% of net assets
- Effective holdings
- 24 equal-weight equivalent
- Largest holding
- MRNA 11.62% Moderna, Inc.
- Annual turnover
- 43.6% of the portfolio traded
All IDNA holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | MRNA | Moderna, Inc. | Healthcare | 11.62% | $37.3M | $87.04B | — |
| 2 | TWST | Twist Bioscience Corporation | Healthcare | 5.52% | $17.7M | $8.80B | — |
| 3 | IOVA | Iovance Biotherapeutics, Inc. | Healthcare | 4.72% | $15.2M | $6.17B | — |
| 4 | GMAB | Genmab A/S | Healthcare | 4.44% | $14.3M | — | — |
| 5 | 4502 | Takeda Pharmaceutical Co. Ltd. | Healthcare | 3.89% | $12.5M | — | — |
| 6 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 3.68% | $11.8M | $81.41B | 19.6 |
| 7 | EXEL | Exelixis, Inc. | Healthcare | 3.64% | $11.7M | $15.42B | 19.6 |
| 8 | RVMD | Revolution Medicines, Inc. | Healthcare | 3.62% | $11.6M | $38.14B | — |
| 9 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 3.53% | $11.3M | $126.66B | 28.9 |
| 10 | MRK | Merck & Co., Inc. | Healthcare | 3.52% | $11.3M | $360.08B | 115.8 |
| 11 | CAI | Caris Life Sciences, Inc. | Healthcare | 3.38% | $10.9M | $8.64B | 18.1 |
| 12 | ROP | Roche Holding AG | Healthcare | 3.32% | $10.7M | — | — |
| 13 | BAYN | Bayer AG NA | Healthcare | 3.26% | $10.5M | — | — |
| 14 | INCY | Incyte Corporation | Healthcare | 3.11% | $10.0M | $22.92B | 14.4 |
| 15 | GSK | GSK plc | Healthcare | 2.94% | $9.5M | — | — |
| 16 | BNTX | BioNTech SE | Healthcare | 2.79% | $9.0M | $22.03B | — |
| 17 | IBRX | ImmunityBio, Inc. | Healthcare | 2.79% | $9.0M | $9.73B | — |
| 18 | IPN | Ipsen SA | Healthcare | 2.63% | $8.5M | — | — |
| 19 | IDYA | IDEAYA Biosciences, Inc. | Healthcare | 2.61% | $8.4M | $3.17B | — |
| 20 | SAN | Sanofi SA | Healthcare | 2.54% | $8.1M | — | — |
| 21 | ABCL | AbCellera Biologics Inc. | Healthcare | 2.37% | $7.6M | $3.82B | — |
| 22 | 4528 | Ono Pharmaceutical Ltd | Healthcare | 1.65% | $5.3M | — | — |
| 23 | RCUS | Arcus Biosciences, Inc. | Healthcare | 1.52% | $4.9M | $2.82B | — |
| 24 | NVAX | Novavax, Inc. | Healthcare | 1.45% | $4.7M | $1.86B | — |
| 25 | CRSP | CRISPR Therapeutics AG | Healthcare | 1.31% | $4.2M | $4.76B | — |
| 26 | VIR | Vir Biotechnology, Inc. | Healthcare | 1.27% | $4.1M | $1.69B | — |
| 27 | NUVB | Nuvation Bio Inc. | Healthcare | 1.04% | $3.3M | $1.56B | — |
| 28 | JANX | Janux Therapeutics, Inc. | Healthcare | 0.92% | $3.0M | $1.01B | — |
| 29 | PSNL | Personalis, Inc. | Healthcare | 0.88% | $2.8M | $1.67B | — |
| 30 | 6887 | SUNSHINE LAKE PHARMA CO LTD | Healthcare | 0.77% | $2.5M | — | — |
| 31 | KURA | Kura Oncology, Inc. | Healthcare | 0.77% | $2.5M | $807.8M | — |
| 32 | VSTM | Verastem, Inc. | Healthcare | 0.76% | $2.5M | $783.4M | — |
| 33 | RIGL | Rigel Pharmaceuticals, Inc. | Healthcare | 0.75% | $2.4M | $858.7M | 2.7 |
| 34 | 2595 | GenFleet Therapeutics | Healthcare | 0.64% | $2.1M | — | — |
| 35 | CRVS | Corvus Pharmaceuticals, Inc. | Healthcare | 0.60% | $1.9M | $800.8M | — |
| 36 | PACB | Pacific Biosciences of California, Inc. | Healthcare | 0.54% | $1.7M | $537.7M | — |
| 37 | XNCR | Xencor, Inc. | Healthcare | 0.53% | $1.7M | $1.70B | — |
| 38 | ALVO | Alvotech | Healthcare | 0.48% | $1.5M | $1.78B | — |
| 39 | DNA | Ginkgo Bioworks Holdings, Inc. | Healthcare | 0.42% | $1.4M | $691.6M | — |
| 40 | NTLA | Intellia Therapeutics, Inc. | Healthcare | 0.40% | $1.3M | $1.60B | — |
| 41 | VLA | Valneva SE | Healthcare | 0.37% | $1.2M | — | — |
| 42 | CTMX | CytomX Therapeutics, Inc. | Healthcare | 0.37% | $1.2M | $496.8M | — |
| 43 | DSGN | Design Therapeutics, Inc. | Healthcare | 0.35% | $1.1M | $645.2M | — |
| 44 | 2696 | Shanghai Henlius Biotech Inc | Healthcare | 0.34% | $1.1M | — | — |
| 45 | 174900 | AbClon Inc | Healthcare | 0.24% | $771,715.71 | — | — |
| 46 | OCGN | Ocugen, Inc. | Healthcare | 0.23% | $737,017.42 | $264.6M | — |
| 47 | PRME | Prime Medicine, Inc. | Healthcare | 0.10% | $315,176.15 | $629.4M | — |
Weights as a percentage of net assets. Value held = weight × net assets ($321.3M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
IDNA sector breakdown
Sum of the weights of the holdings in each sector.
IDNA top industries
IDNA overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| VXUS | Vanguard Total International Stock ETF | 1.8% | 9 of 8,035 | 0.05% |
| DIA | SPDR Dow Jones Industrial Average ETF | 1.7% | 1 of 30 | 0.16% |
| QQQ | Invesco QQQ ETF | 1.5% | 4 of 101 | 0.17% |
| IWM | iShares Russell 2000 ETF | 1.4% | 23 of 1,962 | 0.19% |
| VTI | Vanguard Total Stock Market ETF | 1.1% | 30 of 2,941 | 0.03% |
| SPY | SPDR S&P 500 ETF | 1.0% | 6 of 502 | 0.09% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the IDNA portfolio
iShares Genomics Immunology and Healthcare ETF holds 47 positions. The ten largest make up 48.2% of the fund, so it behaves like a portfolio of about 24 equally weighted stocks. The biggest positions are Moderna, Inc. (11.62%), Twist Bioscience Corporation (5.52%), Iovance Biotherapeutics, Inc. (4.72%), Genmab A/S (4.44%), Takeda Pharmaceutical Co. Ltd. (3.89%).
By sector, Healthcare is 98.6%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 25, 2026; positions change as the fund rebalances.
Related: IDNA chart, IDNA performance, IDNA dividends, IDNA overview.
IDNA holdings FAQ
How many holdings does IDNA have?
IDNA holds 47 positions as of October 25, 2026.
What are the top 10 holdings of IDNA?
The ten largest holdings are Moderna, Inc. (11.62%), Twist Bioscience Corporation (5.52%), Iovance Biotherapeutics, Inc. (4.72%), Genmab A/S (4.44%), Takeda Pharmaceutical Co. Ltd. (3.89%), Regeneron Pharmaceuticals, Inc. (3.68%), Exelixis, Inc. (3.64%), Revolution Medicines, Inc. (3.62%), Vertex Pharmaceuticals Incorporated (3.53%), Merck & Co., Inc. (3.52%). Together they are 48.2% of the fund.
What percentage of IDNA is Moderna, Inc.?
Moderna, Inc. is the largest holding at 11.62% of net assets, about $37.3M of the fund's $321.3M.
How concentrated is IDNA?
The top 10 holdings are 48.2% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) IDNA behaves like a portfolio of about 24 equally weighted stocks.